Abstract:Abstract BACKGROUD: Pancreatic cancer is one of the deadliest types of cancer. Activation and expression of focal adhesion kinase (FAK) and Src kinase is abnormally upregulated in pancreatic cancers. The results of clinical trials targeting either Src or FAK by inhibitors are largely unknown. S100A4 is a calcium-binding protein and aberrant S100A4 expression is an independent biomarker for poor outcomes of pancreatic cancer; however, the involved mechanism is unclear. METHODS: The effects of inhibitors on FAK and Src activation, and on cell migration and growth, were examined in MiaPaca2 and S2VP10 cell lines. To determine whether FAK and Src depend on each other or independently regulate pancreatic cancer cell phenotypes, the effects of FAK or Src mutant expression were determined. The role of S100A4 on FAK and Src activation was evaluated through loss/gain approaches. The association of S100A4 expression with FAK and Src activation was determined by immunostaining on human pancreatic cancer tissue sections. RESULTS: FAK and Src kinase inhibitors blocked activation in a dose dependent manner in both MiaPaca2 and S2VP10 cells. However, it required more inhibitor to inhibit either FAK or Src in S2VP10 cells. Blocking FAK (or Src) does not completely inhibit Src (or FAK) activation. This is confirmed by the finding that FAK mutant expression completely inhibited FAK activation, but not Src activation. Similarly, Src mutant expression did not inhibit FAK activation. Downregulation of S100A4 expression significantly decreased FAK and Src activation. Importantly, increased S100A4 expression is associated with increased FAK and Src activation in pancreatic cancer. CONCLUSIONS: These data support that the Src-FAK axis forms a dual signaling pathway, and each of them contributes independently to the aggressive pancreatic cancer cell phenotype. Also, these data support that S100A4 promotes the Src-FAK dual signaling pathway which possibly leads to a feed-forward loop facilitating pancreatic tumor progression. Citation Format: Guoqiang Cai, Elizabeth H. Kerr, Meng Hu, Youfeng Yang, Donald J. Buchsbaum, William E. Grizzle, Qiang Ding. S100A4 promotes cell migration and growth through focal adhesion kinase and Src mediated dual signaling pathways in pancreatic cancer cells. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4013. doi:10.1158/1538-7445.AM2013-4013

Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer.

Clinicopathological and Prognostic Significance of MUC4 Expression in Cancers: Evidence from Meta-Analysis.

S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase

Expression and Clinical Significance of S100A16 in Pancreatic Cancer

Diagnostic Value of S100P for Pancreatic Cancer: a Meta-Analysis.

Overexpression of S100A4 is Closely Associated with the Progression and Prognosis of Gastric Cancer in Young Patients.

Expressions of S100A4 in lung cancer tissues and its clinical significance

Prognostic Value of S100P Expression in Patients with Digestive System Cancers: A Meta-Analysis

Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer.

Abstract 4013: S100A4 Promotes Cell Migration and Growth Through Focal Adhesion Kinase and Src Mediated Dual Signaling Pathways in Pancreatic Cancer Cells.

Integrated Analysis Identifies S100A16 As a Potential Prognostic Marker for Pancreatic Cancer.

Expression Status of S100A14 and S100A4 Correlates with Metastatic Potential and Clinical Outcome in Colorectal Cancer after Surgery.

S100A4 Over-Expression Underlies Lymph Node Metastasis and Poor Prognosis in Colorectal Cancer.

S100A4 Overexpression in Pancreatic Ductal Adenocarcinoma: Imaging Biomarkers from Whole-Tumor Evaluation with MRI and Texture Analysis

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer

[Correlations of S100A4 Protein Expression to Invasion and Metastasis of Non-Small Cell Lung Cancer].

Increased Sphingosine Kinase 1 Expression is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis

P2-025: the Correlation of the Differential Expression of S100A4 Gene (mts1) with the Differentiation and Metastasis of Lung Cancer

Expression of S100 mRNA in pancreatic carcinoma

Overexpression of S100A2 Protein As a Prognostic Marker for Patients with Stage I Non Small Cell Lung Cancer

Expression of S100A4 and matrix metalloproteinase 2 and their correlations with clinicopathological features in esophageal squamous cell carcinoma